SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Angiology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Kolovou, G. D.
Right arrow Articles by Cokkinos, D. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kolovou, G. D.
Right arrow Articles by Cokkinos, D. V.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Association of Apolipoprotein E Genotype with Early Onset of Coronary Heart Disease in Greek Men

Genovefa D. Kolovou, MD, PhD

Department of Molecular Immunology Laboratory, Onassis Cardiac Surgery Center, Athens, Greece, genkolovou{at}mail.gr

Katherine K. Anagnostopoulou, MSc

Department of Molecular Immunology Laboratory, Department of Cardiac Surgery, Onassis Cardiac Surgery Center, Athens, Greece

Dimitri P. Mikhailidis, MD

Department of Clinical Biochemistry (Vascular Disease Prevention Clinics), Royal Free Hospital, Royal Free and University College Medical School, London, UK

Demosthenes B. Panagiotakos, PhD

Department of Molecular Immunology Laboratory, Onassis Cardiac Surgery Center, Athens, Greece, Harokopio University, Athens, Greece

Nektarios D. Pilatis, MD

Department of Molecular Immunology Laboratory, Onassis Cardiac Surgery Center, Athens, Greece

Marios A. Cariolou, MSc, PhD

The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus

Nikos Yiannakouris, PhD

Harokopio University, Athens, Greece

Dimitris Degiannis, MD, PhD

Department of Cardiac Surgery, Onassis Cardiac Surgery Center, Athens, Greece

Georgios Stavridis, MD

Department of Molecular Immunology Laboratory, Onassis Cardiac Surgery Center, Athens, Greece

Dennis V. Cokkinos, MD

Department of Molecular Immunology Laboratory, Onassis Cardiac Surgery Center, Athens, Greece

Apolipoprotein (apo) E polymorphism has been associated with coronary heart disease (CHD) although its relation to the age of CHD onset is still not defined. The age of onset of established CHD was obtained from 502 Greek men and compared to 103 healthy men. The age grouping was based on the age of CHD onset (earlier ≤44 years, n=73, intermediate 45-64 years, n=321, and later ≥65 years, n=108). Apo E genotyping was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and the lipid profile was assessed. No differences in genotype and allele frequencies were found within the CHD groups. The apo {epsilon}3/4 genotype and the apo {epsilon}4 allele were less frequent in the earlier-onset group than in healthy men (11.0% vs 22.3%, Pearson Chi-Square p=0.028 and 6.8% vs 13.6%, Pearson Chi-Square p=0.023, respectively). The lipid profile was similar in all genotypes of all groups except for high-density lipoprotein cholesterol levels, which were higher in {epsilon}2 carriers compared to non-{epsilon}2 carriers (in mg/dL [±SD]; 44 [9] vs 39 [10], in mmol/L [±SD]; 1.1 [0.2] vs 1.0 [0.3] p=0.005). There is an association between apo E genotype and early onset of CHD in Greek men. In the earlier CHD onset group, the apo {epsilon}3/4 genotype was less frequent compared to healthy men. This supports that the apo {epsilon}3/4 genotype is associated with decreased risk of premature CHD. Because the results of similar studies are not consistent, it may be that the relationship between apo E genotype and CHD is related to ethnicity rather than a universal phenomenon.

Angiology, Vol. 56, No. 6, 663-670 (2005)
DOI: 10.1177/000331970505600603


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




Advertisement